Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
Top Cited Papers
- 31 December 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 129 (1), 104-U147
- https://doi.org/10.1016/j.jaci.2011.08.031
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthmaJournal of Allergy and Clinical Immunology, 2010
- Airway Wall Expression of OX40/OX40L and Interleukin-4 in AsthmaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Thymic stromal lymphopoietin: a new cytokine in asthmaCurrent Opinion in Pharmacology, 2008
- Secretion of IL-13 by Airway Epithelial Cells Enhances Epithelial Repair via HB-EGFAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammationJCI Insight, 2007
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsThe Journal of Experimental Medicine, 2007
- Predictors of therapy resistant asthma: outcome of a systematic evaluation protocolThorax, 2003
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002